The treatment of intermittent claudication with betapyridyl carbinol over two years.
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003692:Delayed-Action Preparations; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D007383:Intermittent Claudication / Q000097:blood / Q000188:drug therapy*; D008297:Male; D000432:Methanol / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D009539:Nicotinic Acids; D010919:Placebos; D011725:Pyridines; D014280:Triglycerides; D014665:Vasodilator Agents; D002784:Cholesterol; D000432:Methanol